Biomarker

Associations between urinary 3-indoxyl sulfate, a gut microbiome-derived biomarker, and patient outcomes after intensive care unit admission

Highlights: (1) The normal gut microbiome is disrupted in patients who are critically ill. (2) 3-indoxyl sulfate is a gut bacteria byproduct that is excreted in the urine. (3) Evaluate urine 3-indoxyl sulfate as a gut-specific biomarker in the ICU population.